The Technical Analyst
Nanovibronix Inc [NAOV]
Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices
Nanovibronix Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
-3.24% $0.750
America/New_York / 18 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 2.09 mill |
| EPS: | -2.12 |
| P/E: | -0.350 |
| Earnings Date: | May 13, 2024 |
| SharesOutstanding: | 2.78 mill |
| Avg Daily Volume: | 0.100 mill |
| RATING 2024-04-18 |
|---|
| C+ |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Sell | |
| DE: | Neutral | |
| P/E: | Neutral | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.350 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.00x |
| Company: PE -0.350 | industry: PE 222.16 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.668 - 0.832 ( +/- 10.93%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-01-23 | Mika Thomas | Buy | 16 666 | Option to Purchase Common Stock |
| 2024-01-23 | Jacob Harold | Buy | 6 667 | Option to Purchase Common Stock |
| 2024-01-23 | Schroeder Maria | Buy | 16 667 | Option to Purchase Common Stock |
| 2024-01-23 | Ferguson Michael | Buy | 16 666 | Option to Purchase Common Stock |
| 2024-01-23 | Goldstein Martin M | Buy | 16 667 | Option to Purchase Common Stock |
| INSIDER POWER |
|---|
| 29.41 |
| Last 97 transactions |
| Buy: 2 103 083 | Sell: 846 526 |
Forecast:
16:00 - $0.750
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $0.750
Forecast 2: 16:00 - $0.750
Forecast 3: 16:00 - $0.750
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $0.750 (-3.24% ) |
| Volume | 0.0035 mill |
| Avg. Vol. | 0.100 mill |
| % of Avg. Vol | 3.46 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For NAOV
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
NAOV
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was incorporated in 2003 and is based in Elmsford, New York.
Latest Press Releases
2024-04-09 08:30:00 - Press Release
Nanovibronix Issues Letter To Stockholders
Elmsford, n.y.--(business wire)--nanovibronix, inc., (nasdaq: naov)(“nanovibronix”), a medical device company that produces the uroshield®, painshield® and woundshield® surface acoustic wave (saw) portable ultrasonic therapeutic devices, today issued a letter to stockholders from its chief executive officer, brian murphy, providing a review of the fourth quarter and full year 2023 and recent business developments. to our shareholders: we are committed to our strategic vision of developing, impr.
2024-03-28 08:30:00 - Press Release
Nanovibronix Signs Agreement For Research And Development Of Next Generation Painshield And Uroshield
Elmsford, n.y.--(business wire)--nanovibronix, inc. (nasdaq: naov) (“nanovibronix” or the “company”), a medical device company that produces the uroshield®, painshield® and woundshield® surface acoustic wave (saw) portable ultrasonic therapeutic devices, today announced it has entered into an agreement with veranex, inc. (“veranex”) to assist with the development of the company's next generation uroshield and painshield products. under the terms of the agreement, veranex will provide certain re.
2023-12-06 09:00:00 - Press Release
Nanovibronix Featured In Your Bladder Health Magazine
Elmsford, n.y.--(business wire)--nanovibronix, inc., (nasdaq: naov), a medical device company that produces the uroshield®, painshield® and woundshield® surface acoustic wave (saw) portable ultrasonic therapeutic devices, today announced that its uroshield is featured in issue 103 of your bladder health magazine in an article titled ‘uroshield prevention is better than cure.' the article highlights the effectiveness of using uroshield in the prevention of catheter associated urinary tract infec.
2023-12-04 09:00:00 - Press Release
Nanovibronix Enters Into Letter Of Intent With Apogepha Arzneimittel Gmbh To Explore European Distribution Opportunity
Elmsford, n.y.--(business wire)--nanovibronix, inc. (nasdaq: naov), a medical device company that produces the uroshield®, painshield® and woundshield® surface acoustic wave (saw) portable ultrasonic therapeutic devices, today announced that it has entered into a non-binding letter of intent (the “loi”) with apogepha arzneimittel gmbh (“apogepha”) in which both parties will analyze the potential for apogepha to distribute nanovibronix's premiere uroshield product in germany and other european m.
2023-11-28 09:00:00 - Press Release
Nanovibronix Announces Agreement For Clinical Study Of Uroshield At The University Of Michigan
Elmsford, n.y.--(business wire)--nanovibronix, inc. (nasdaq: naov), a medical device company that produces the uroshield®, painshield® and woundshield® surface acoustic wave (saw) portable ultrasonic therapeutic devices, today announced it has signed a research agreement with the regents of the university of michigan for a randomized control trial (“rct”) study of uroshield. brian murphy, chief executive officer of nanovibronix, inc., said, “we are partnering with a team of distinguished resear.
Latest News
2023-11-07 09:26:29 - PennyStocks
Penny Stocks To Buy Now? 3 to Watch With Big News
Let's talk penny stocks, those under-five-dollar shares that buzz with potential. They're nimble, sensitive to the slightest news, and can pivot on a dime.
2022-11-29 10:32:21 - InvestorPlace
What Is Going on With NanoVibronix (NAOV) Stock Today?
NanoVibronix (NASDAQ: NAOV ) stock is falling on Tuesday following news of a registered direct offering from the therapeutic ultrasound technology company. This direct offering has NanoVirbronix agreeing to sell 4.8 million shares of NAOV stock to several institutional investors.
2022-09-24 11:31:00 - PennyStocks
Long Term Penny Stocks Investing Strategy (Complete Guide)
Use this guide for investing in penny stocks in the long term The post Long Term Penny Stocks Investing Strategy (Complete Guide) appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
2022-09-14 16:05:00 - Business Wire
NanoVibronix Sets Date for Annual Shareholder Meeting
ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc., (NASDAQ: NAOV) (the “Company”), announced today that its annual meeting of shareholders (the “Annual Meeting”) will take place at 10 a.m. Eastern time on December 15, 2022. The Company will hold the Annual Meeting virtually via the internet. The record date for determination of shareholders entitled to vote at the Annual Meeting is October 17, 2022. The Company anticipates sending proxy materials for the Annual Meeting to stockholders in Nove
2022-03-30 15:30:26 - PennyStocks
Best Penny Stocks to Buy Now? Here's 3 to Watch in April 2022
Can these penny stocks continue to make moves next month? The post Best Penny Stocks to Buy Now?
2022-03-30 13:41:41 - InvestorPlace
Top Penny Stocks Today: Why Are ADGI, DRCT, VYNT, NAOV, GERN and SNOA Rising Today?
Penny stocks are a hot subject today with several of the top companies in the market seeing major gains on Wednesday and we know why! The post Top Penny Stocks Today: Why Are ADGI, DRCT, VYNT, NAOV, GERN and SNOA Rising Today?
2022-03-30 11:27:05 - Benzinga
Health Canada Approves NanoVibronix's PainGuard, UroGuard As Licensed Devices
NanoVibronix Inc's (NASDAQ: NAOV) PainGuard and UroGuard have been approved by Health Canada / Santé Canada as licensed medical devices. The products are offered as private label products through Ideal Medical International Limited.
2021-12-21 15:15:22 - Benzinga
NanoVibronix, Medina Ink Distribution Pact For Ultrasound Devices In Europe
NanoVibronix Inc (NASDAQ: NAOV) has commenced sales in Europe by signing a distribution agreement with Medina Healthcare Ltd for UroShield and PainShield devices. UroShield is an ultrasound-based product designed to prevent bacterial colonization and biofilm on indwelling urinary catheters and increase antibiotic efficacy, ultimately reducing the incidence of catheter-associated urinary tract infections (CAUTI).
2021-10-12 09:06:52 - PennyStocks
Top Penny Stocks to Know in Mid-October 2021? 3 to Watch
Are these penny stocks on your October watchlist? The post Top Penny Stocks to Know in Mid-October 2021?
2021-10-11 10:40:13 - Benzinga
NanoVibronix Shares Gain As PainShield Shows Effectiveness In Treating Soft Tissue Pain
NanoVibronix Inc (NASDAQ:NAOV) has announced results from a randomized, double-blind study to evaluate the safety and effectiveness of the NanoVibronix PainShield. Related: NanoVibronix Launches CBD-Based Product For Pain Management.